drugset / Trial / NCT00241904
Reducing Total Cardiovascular Risk in an Urban Community
Phase 4
Completed
525 enrolled
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Timeline
- Start
- 2006-05
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Atenolol | Other / unclassified | — | Oral |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | — | Oral |
| Subject | Metoprolol | Other / unclassified | — | Oral |
| Subject | Propranolol | Small molecule | — | Oral |